Pulse Biosciences, Inc Common Stock (DE) PLSE
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $58.00 (+7.7% upside)
Key Stats
- Today's Range
- $50.24 – $54.29
- 50-Day Range
- $24.94 – $58.90
- 52-Week Range
- $12.56 – $58.90
- Volume
- 865K shs
- Average Volume
- 610K shs
- Market Cap
- $3.84 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 38.61
- Price / Sales
- 3242.32
Short Interest
- Short Interest
- 2.24%
- Days to Cover
- 12.05
Financials (TTM)
- Revenue
- $1.19 million
- Net Income
- $-80,056,000
- Net Margin
- -6755.78%
- Return on Equity
- -80.46%
- Debt-to-Equity
- —
About Pulse Biosciences, Inc Common Stock (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Related Stocks
Compare head-to-head: PLSE vs SYK·PLSE vs BSX·PLSE vs RMD·PLSE vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.